Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Primed to resolve: A single cell atlas of the shoulder capsule reveals a cellular basis for resolving inflammatory fibrosis

Ng MTH. et al, (2023)

A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and mice.

Hackstein C-P. et al, (2022), Nature communications, 13

MR1: An unconventional twist in the tail.

Phalora P. and Klenerman P., (2022), The Journal of cell biology, 221

Prostaglandins differentially modulate mucosal associated invariant T cell activation and function according to stimulus.

Mehta H. et al, (2022), Immunology and cell biology

Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease.

Wellens J. et al, (2022), Gut, 71, 1919 - 1922

Correction to: MAIT cells in liver inflammation and fibrosis.

Mehta H. et al, (2022), Seminars in immunopathology

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses

McNaughton AL. et al, (2022), JCI Insight, 7

MAIT cells in liver inflammation and fibrosis.

Mehta H. et al, (2022), Seminars in immunopathology

Defining the key intrahepatic gene networks in HCV infection driven by sex.

Marchi E. et al, (2022), Gut

SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients

Shankar S. et al, (2022), Journal of the American Society of Nephrology, 33, 883 - 887

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

Ogbe A. et al, (2022), JCI Insight, 7

CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination

Sharpe HR. et al, (2022), JCI Insight, 7

Human MAIT cells show clonal diversity but transcriptional and functional homogeneity

Garner LC. et al, (2022)

Comparison of two T cell assays to evaluate T cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers

Phillips E. et al, (2022)

An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

Peng Y. et al, (2022), Nature Immunology, 23, 50 - 61

Human MAIT cells respond to and suppress HIV-1.

Phetsouphanh C. et al, (2021), eLife, 10

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

Townsend A. et al, (2021), Nature Communications, 12

Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19

Luo J. et al, (2021), Allergy, Asthma & Clinical Immunology, 17

Real-time seroprevalence and exposure levels of emerging pathogens in infection-naive host populations

Pinotti F. et al, (2021), Scientific Reports, 11

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

Ogbe A. et al, (2021), Nature Communications, 12

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?